Jianfan Biotech (300529.SZ) announced 2024 annual results, with net profit of 820 million yuan to mother, an increase of 87.91% over the previous year

According to the Zhitong Finance App, Jianfan Biotech (300529.SZ) released its 2024 annual report. During the reporting period, the company achieved revenue of 2,677 billion yuan, an increase of 39.27% over the previous year. Achieved net profit of 820 million yuan attributable to shareholders of listed companies, an increase of 87.91% over the previous year. Achieved net profit of 779 million yuan after deducting non-recurring profit and loss attributable to shareholders of listed companies, an increase of 90.46% over the previous year. Basic earnings per share were $1.05. It is proposed to distribute a cash dividend of 8.00 yuan (tax included) for every 10 shares to all shareholders.